CSF Cytokine Characteristics Defined from Children with Meningitis
By LabMedica International staff writers Posted on 21 Jan 2020 |
Image: The BD Bactec FX40: the blood culturing instruments used with patented resin-containing media have shown higher rates of organism recovery, allowing for proper diagnosis and treatment of bloodstream infections (Photo courtesy of Becton, Dickinson and Company).
Enteroviral meningitis (EVM) are the most common etiological agent for viral encephalitis, and are predominantly reported among children and always present as a milder clinical illness than other infectious causes which only need supportive therapy.
However, bacterial meningitis (BM) is still associated with a high morbidity and mortality rate. Appropriate antibiotics treatment is essential to optimize outcomes. Cytokines are regarded as having important roles in meningeal inflammation in patients with central nervous system (CNS) infection.
Clinical scientists at the Zhejiang University School of Medicine (Hangzhou, China) carried a retrospective study and collected cerebrospinal fluid CSF and/or blood specimens for microbiological culture, viruses, and cytokine detection. Patients were categorized into three groups: EVM group: Patients with EVM were confirmed by the presence of pleocytosis and detection of enteroviral nucleic acid detection in CSF using polymerase chain reaction (PCR); BM group: Patients with bacterial meningitis who were diagnosed as having significant CSF white blood cell counts; Control group: children with febrile seizures who underwent lumbar puncture and had normal CSF.
CSF specimens and blood samples were taken for microbiological culture. Samples were injected into children's blood culture bottles (BACTEC FX400, Becton, Dickinson and Company, Franklin Lakes, NJ, USA) for enrichment culture. MALDI‐TOF (BRUKER, Billerica, MA, USA) was used for bacterial identification and VITEK 2 compact (bioMérieux, Marcy-l'Étoile, France) for bacterial drug sensitivity. Serum and CSF concentration of cytokines interleukin (IL)‐2, IL‐6, IL‐10, tumor necrosis factor (TNF), and interferon (IFN)‐γ were quantitatively determined by the CBA kit–BD CBA Human Th1/Th2 Cytokine Kit II (BD Biosciences, San Jose, CA, USA). The detection of EVs was performed by using commercial one‐step real‐time RT‐PCR assay kit.
The scientists reported that 43 patients were confirmed with meningitis, 27 patients with EVM, and 16 with BM. Children with EVM were older compared with BM and control group. Serum IL‐6 and serum IL‐10 were lower in EVM group than BM and control group. IL‐6, IL‐10, and IFN‐γ levels showed obviously increase in CSF in EVM group, while only IL‐6 increased in CSF in BM group. CSF concentrations of cytokines IL‐6, IL‐10, TNF, and IFN‐γ in children with EVM and BM were both higher than control group, but compared EVM group to BM group, CSF IL‐2, TNF, and IFN‐γ showed no difference between two groups.
The authors concluded that CSF cytokines elevated in both virus and bacterial meningitis, while serum elevation only occurred in bacterial infection. However, they could not distinguish enteroviral meningitis from bacterial meningitis with the parameters of CSF cytokines IL‐2, IL‐6, IL‐10, TNF, and IFN‐γ. The study was published on January 8, 2020 in the Journal of Clinical Laboratory Analysis.
Related Links:
Zhejiang University School of Medicine
Becton, Dickinson and Company
BRUKER
bioMérieux
BD Biosciences
However, bacterial meningitis (BM) is still associated with a high morbidity and mortality rate. Appropriate antibiotics treatment is essential to optimize outcomes. Cytokines are regarded as having important roles in meningeal inflammation in patients with central nervous system (CNS) infection.
Clinical scientists at the Zhejiang University School of Medicine (Hangzhou, China) carried a retrospective study and collected cerebrospinal fluid CSF and/or blood specimens for microbiological culture, viruses, and cytokine detection. Patients were categorized into three groups: EVM group: Patients with EVM were confirmed by the presence of pleocytosis and detection of enteroviral nucleic acid detection in CSF using polymerase chain reaction (PCR); BM group: Patients with bacterial meningitis who were diagnosed as having significant CSF white blood cell counts; Control group: children with febrile seizures who underwent lumbar puncture and had normal CSF.
CSF specimens and blood samples were taken for microbiological culture. Samples were injected into children's blood culture bottles (BACTEC FX400, Becton, Dickinson and Company, Franklin Lakes, NJ, USA) for enrichment culture. MALDI‐TOF (BRUKER, Billerica, MA, USA) was used for bacterial identification and VITEK 2 compact (bioMérieux, Marcy-l'Étoile, France) for bacterial drug sensitivity. Serum and CSF concentration of cytokines interleukin (IL)‐2, IL‐6, IL‐10, tumor necrosis factor (TNF), and interferon (IFN)‐γ were quantitatively determined by the CBA kit–BD CBA Human Th1/Th2 Cytokine Kit II (BD Biosciences, San Jose, CA, USA). The detection of EVs was performed by using commercial one‐step real‐time RT‐PCR assay kit.
The scientists reported that 43 patients were confirmed with meningitis, 27 patients with EVM, and 16 with BM. Children with EVM were older compared with BM and control group. Serum IL‐6 and serum IL‐10 were lower in EVM group than BM and control group. IL‐6, IL‐10, and IFN‐γ levels showed obviously increase in CSF in EVM group, while only IL‐6 increased in CSF in BM group. CSF concentrations of cytokines IL‐6, IL‐10, TNF, and IFN‐γ in children with EVM and BM were both higher than control group, but compared EVM group to BM group, CSF IL‐2, TNF, and IFN‐γ showed no difference between two groups.
The authors concluded that CSF cytokines elevated in both virus and bacterial meningitis, while serum elevation only occurred in bacterial infection. However, they could not distinguish enteroviral meningitis from bacterial meningitis with the parameters of CSF cytokines IL‐2, IL‐6, IL‐10, TNF, and IFN‐γ. The study was published on January 8, 2020 in the Journal of Clinical Laboratory Analysis.
Related Links:
Zhejiang University School of Medicine
Becton, Dickinson and Company
BRUKER
bioMérieux
BD Biosciences
Latest Microbiology News
- Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
- Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia
- Rapid AST Platform Provides Targeted Therapeutic Results Days Faster Than Current Standard of Care
- New Analysis Method Detects Pathogens in Blood Faster and More Accurately by Melting DNA